FindTrial
Sign In

Study on the Effect of Circulating Immune Cells in neoadjuvant Immunotherapy for Advanced Gastric Cancer: A single-center prospective cohort study

Study on the Effect of Circulating Immune Cells in neoadjuvant Immunotherapy for Advanced Gastric Cancer: A single-center prospective cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600118711
Enrollment
Unknown
Registered
2026-02-10
Start date
2026-02-19
Completion date
Unknown
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

Case series:None

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 18 to 75 with advanced gastric cancer; 2. Neoadjuvant therapy is needed (immunotherapy, chemotherapy + immunotherapy); 3. The patient voluntarily and agrees to join the clinical research;

Exclusion criteria

Exclusion criteria: 1.Gastric cancer combined with invasion and metastasis; 2. Gastric cancer combined with other malignant tumors; 3. Gastric cancer combined with dysfunction of other organs; 4. Unwilling to participate in clinical research.

Design outcomes

Primary

MeasureTime frame
Response to neoadjuvant immunotherapy; complete remission;Relapse-free survival;Overall survival rate;CD3+ immune cells;—

Countries

China

Contacts

Public ContactWang Yong

West China Hospital, Sichuan University

wy642192587@163.com+86 134 0866 4825

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026